iSpecimen Inc. (ISPC)
NCM · Diagnostics & Research
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. The company's marketplace offers human biospecimens, including biofluids, such as whole blood, plasma, serum, urine, saliva, sputum, nasopharyngeal material, and cerebral spinal fluid; solid tissue comprising fresh, fixed, and cryopreserved tissue, as well as formalin-fixed paraffin embedded blocks, slides, and curls; and hematopoietic stem and immune cells, including bone marrow, cord blood, whole blood, or sub-components of these tissues, such as peripheral blood mononuclear cells and other isolated cell types. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Woburn, Massachusetts.
Peers in Diagnostics & Research
All in industry →Thermo Fisher Scientific Inc.
Danaher Corporation
IDEXX Laboratories, Inc.
Agilent Technologies, Inc.
Waters Corporation
Natera, Inc.
IQVIA Holdings Inc.
Mettler-Toledo International Inc.
Labcorp Holdings Inc.
Quest Diagnostics Incorporated
Recent press releases
iSpecimen Inc. has not issued a press release in this window.
SEC filings
All filings →iSpecimen Inc. has not filed an SEC document in this window.
Insider trades
All insider trades →iSpecimen Inc. has no reported insider trades in the last 90 days.